Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trialIvan Fan-Ngai Hung, Kwok-Yung Yuen, Kwok-Cheung Lung et al.|The Lancet|2020Cited by 1.6k
Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational studyHin Chu, Kwok‐Yung Yuen, Jasper Fuk‐Woo Chan et al.|The Lancet Microbe|2020Cited by 838
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome SequencingKelvin Kai‐Wang To, Kwok‐Yung Yuen, Ivan Fan‐Ngai Hung et al.|Clinical Infectious Diseases|2020Cited by 818
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cellsHanjun Zhao, Kelvin Kai‐Wang To, Lu Lu et al.|Emerging Microbes & Infections|2021Cited by 474
Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamstersShuofeng Yuan, Jasper Fuk‐Woo Chan, Zi‐Wei Ye et al.|Science|2022Cited by 222